Moisand Fitzgerald Tamayo’s Core Laboratories CLB Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-78	Closed	-$899	–	580
2025 Q2	$899	Hold	78	–	–	﹤0.01%	543
2025 Q1	$1.17K	Hold	78	–	–	﹤0.01%	531
2024 Q4	$1.35K	Hold	78	–	–	﹤0.01%	537
2024 Q3	$1.45K	Hold	78	–	–	﹤0.01%	545
2024 Q2	$1.58K	Hold	78	–	–	﹤0.01%	516
2024 Q1	$1.33K	Hold	78	–	–	﹤0.01%	513
2023 Q4	$1.38K	Sell	78 -102	-57%	-$2.06K	﹤0.01%	572
2023 Q3	$4.32K	Hold	180	–	–	﹤0.01%	450
2023 Q2	$4.18K	Hold	180	–	–	﹤0.01%	434
2023 Q1	$3.97K	Hold	180	–	–	﹤0.01%	446
2022 Q4	$3.65K	Buy	180 +78	+76%	+$1.51K	﹤0.01%	447
2022 Q3	$1K	Buy	+102	New	+$1.72K	﹤0.01%	579

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Moisand Fitzgerald Tamayo's CLB Position: Q3 2025 in Review

Moisand Fitzgerald Tamayo sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 78 shares — an estimated $899 sold.

Moisand Fitzgerald Tamayo first reported a position in CLB in Q3 2022 and held it in 12 quarters. The position peaked at $4.32K in Q3 2023. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

Moisand Fitzgerald Tamayo reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
Moisand Fitzgerald Tamayo sold 78 Core Laboratories shares in Q3 2025, an estimated $899.
Moisand Fitzgerald Tamayo first reported a position in Core Laboratories in Q3 2022 and held it in 12 quarters.
Moisand Fitzgerald Tamayo's Core Laboratories position peaked at $4.32K in Q3 2023.
190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q3 2025, filed 23 Oct 2025.